地高辛与中药合用的4种死法

2016-06-01 药评中心 药评中心

王大爷,67岁,患有慢性心力衰竭,每天口服地高辛片0. 25mg,症状控制良好。初春气温变化大,王大爷不少心着了凉,出现发热、咳嗽、咽喉肿痛、腹泻、周身不适等感冒症状。王大爷去附近的药店购买了黄连素片、羚羊感冒片,以及店员推荐的六神丸和急支糖浆。   让药店员工没想到的是,王大爷口服上述药物5天后,发生地高辛中毒,最后抢救无效死亡。王大爷家人把药店告上了法院。现在让我们一起来找茬,看

王大爷,67岁,患有慢性心力衰竭,每天口服地高辛片0. 25mg,症状控制良好。初春气温变化大,王大爷不少心着了凉,出现发热、咳嗽、咽喉肿痛、腹泻、周身不适等感冒症状。王大爷去附近的药店购买了黄连素片、羚羊感冒片,以及店员推荐的六神丸和急支糖浆。
 
让药店员工没想到的是,王大爷口服上述药物5天后,发生地高辛中毒,最后抢救无效死亡。王大爷家人把药店告上了法院。现在让我们一起来找茬,看看什么药物引起了地高辛中毒。

1、黄连素片

地高辛属强心苷类药物,常用剂量为0.125~0.5mg,每日一次。地高辛治疗剂量与中毒量接近,个体差异大,当与其它药物联用时,易因药物相互作用导致地高辛中毒,发生室性早搏、室性心动过速、房室传导阻滞,心室颤动等致命性心律失常
 
地高辛是一种经典的P-糖蛋白(P-gp)底物。肠道中的P-糖蛋白可把肠上皮细胞内的地高辛主动转运至肠腔,使其吸收减少,降低其生物利用度和体内血药浓度。
 
黄连素是临床常用的药物,患者自行服药现象相当普遍。国内外研究证明,黄连素(小檗碱)对P-糖蛋白有抑制作用。黄连素与地高辛联用,无论单剂量还是多剂量,均不同程度的提高地高辛的生物利用度和峰浓度,可引起地高辛中度。

2、六神丸 

六神丸由牛黄、麝香、冰片、蟾酥、珍珠、雄黄6味药材组成。具有清凉解毒,消炎止痛之功,用于烂喉丹痧,咽喉肿痛,喉风喉痈,痈疡疔疮,乳痈发背,无名肿毒等。
 
六神丸中含有蟾酥。实验研究和临床实践均证明,蟾酥的主要成分蟾毒素及蟾毒配基具有强心苷元结构,有与洋地黄相似的强心作用,但强心作用较弱,且易引起窦性心动过缓,房室传导阻滞,室性早搏等。蟾酥与地高辛合用时,强心作用增强,易引起中毒反应。
 
据文献报道,某女性患者,患风湿性心脏病15年,因房颤,长期应用地高辛维持;又因颈部疖肿而服六神丸,每次10粒,共30粒,出现频发性室性早搏。

3、急支糖浆

急支糖浆中含有麻黄。麻黄主要成分为麻黄碱,具有兴奋心脏α受体和β受体的作用,能兴奋心肌,加强心肌收缩力。麻黄碱可使地高辛的作用增强,毒性增加,且易导致心律失常及心力衰竭等不良反应。
 
据报道, 某65岁男性患者,因咳痰、气喘入院。诊断为阻塞性肺气肿、心功能Ⅲ级。予以麻黄为君药的小青龙汤等中西药治疗。一周后咳喘明显缓解,双下肢仍浮肿,活动后稍感心慌、气急,加服地高辛1次0.25mg,1次/d,4d后出现心悸,心率93次/min,心律不齐,早搏19次/min。经静推利多卡因,停用地高辛后,早搏消失。一月后,小青龙汤与地高辛再次合用,又出现类似情况,停用小青龙汤,只服地高辛,早搏未再出现。

4、羚羊感冒片

甘草主要成分为甘草甜素和甘草次酸,化学结构与皮质酮类似,具有去氧皮质酮样作用。大量服用甘草1~4周,或小量长期口服甘草制剂(含甘草9g)时,部分患者就可能出现水肿、四肢无力、痉挛麻木、头晕、头痛、血压升高、低血钾等。
 
羚羊感冒片和急支糖浆中均含有甘草,两者联用甘草量加大。同时服用羚羊感冒片和急支糖浆有可能引起患者低血钾,使心脏对地高辛的敏感性增强,诱发地高辛中毒。
 
总之,中西药联用非常普遍,使用不当就可能发生不良相互作用。老年人心血管疾病发生率较高,老年患者可能正在长期服用他汀类、地高辛、阿司匹林等心血管药物。医生应主动询问用药史,预防不良相互作用的发生。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=110849, encodeId=991a11084920, content=赞!好文章,拜读,值得深入学习!中西药混用真的要谨慎啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Sep 04 14:56:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99925, encodeId=499a99925d6, content=中西药结合应用要谨慎。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Aug 17 17:49:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390684, encodeId=0931139068444, content=<a href='/topic/show?id=74b24141445' target=_blank style='color:#2F92EE;'>#地高辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41414, encryptionId=74b24141445, topicName=地高辛)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Fri Jun 03 06:11:00 CST 2016, time=2016-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88215, encodeId=ac47882155e, content=非常好的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Thu Jun 02 07:25:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88102, encodeId=b70488102b3, content=不错,加深学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 20:26:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2016-09-04 ylzr123

    赞!好文章,拜读,值得深入学习!中西药混用真的要谨慎啊!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=110849, encodeId=991a11084920, content=赞!好文章,拜读,值得深入学习!中西药混用真的要谨慎啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Sep 04 14:56:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99925, encodeId=499a99925d6, content=中西药结合应用要谨慎。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Aug 17 17:49:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390684, encodeId=0931139068444, content=<a href='/topic/show?id=74b24141445' target=_blank style='color:#2F92EE;'>#地高辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41414, encryptionId=74b24141445, topicName=地高辛)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Fri Jun 03 06:11:00 CST 2016, time=2016-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88215, encodeId=ac47882155e, content=非常好的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Thu Jun 02 07:25:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88102, encodeId=b70488102b3, content=不错,加深学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 20:26:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2016-08-17 jyzxjiangqin

    中西药结合应用要谨慎。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=110849, encodeId=991a11084920, content=赞!好文章,拜读,值得深入学习!中西药混用真的要谨慎啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Sep 04 14:56:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99925, encodeId=499a99925d6, content=中西药结合应用要谨慎。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Aug 17 17:49:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390684, encodeId=0931139068444, content=<a href='/topic/show?id=74b24141445' target=_blank style='color:#2F92EE;'>#地高辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41414, encryptionId=74b24141445, topicName=地高辛)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Fri Jun 03 06:11:00 CST 2016, time=2016-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88215, encodeId=ac47882155e, content=非常好的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Thu Jun 02 07:25:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88102, encodeId=b70488102b3, content=不错,加深学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 20:26:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=110849, encodeId=991a11084920, content=赞!好文章,拜读,值得深入学习!中西药混用真的要谨慎啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Sep 04 14:56:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99925, encodeId=499a99925d6, content=中西药结合应用要谨慎。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Aug 17 17:49:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390684, encodeId=0931139068444, content=<a href='/topic/show?id=74b24141445' target=_blank style='color:#2F92EE;'>#地高辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41414, encryptionId=74b24141445, topicName=地高辛)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Fri Jun 03 06:11:00 CST 2016, time=2016-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88215, encodeId=ac47882155e, content=非常好的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Thu Jun 02 07:25:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88102, encodeId=b70488102b3, content=不错,加深学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 20:26:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2016-06-02 1de00086m73(暂无匿称)

    非常好的东西。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=110849, encodeId=991a11084920, content=赞!好文章,拜读,值得深入学习!中西药混用真的要谨慎啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Sep 04 14:56:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99925, encodeId=499a99925d6, content=中西药结合应用要谨慎。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Aug 17 17:49:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1390684, encodeId=0931139068444, content=<a href='/topic/show?id=74b24141445' target=_blank style='color:#2F92EE;'>#地高辛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41414, encryptionId=74b24141445, topicName=地高辛)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Fri Jun 03 06:11:00 CST 2016, time=2016-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88215, encodeId=ac47882155e, content=非常好的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Pw2csslt7CukWiabqiblnQAbAss3ANsjUWZKUgN2n3JyJDHOJJAxibetNCiaEh70YckbPPTELyyStMZ8T3Q340icNSXgj72MowgTC/0, createdBy=188f1666747, createdName=1de00086m73(暂无匿称), createdTime=Thu Jun 02 07:25:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88102, encodeId=b70488102b3, content=不错,加深学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Wed Jun 01 20:26:00 CST 2016, time=2016-06-01, status=1, ipAttribution=)]
    2016-06-01 沉心多思

    不错,加深学习了

    0

相关资讯

JACC:地高辛增房颤者死亡风险添新证

一项在新诊断心房颤动(以下简称房颤)老年退伍人群中进行的大型队列研究显示,那些接受初始地高辛治疗的患者的3年内死亡风险增加>20%,这种风险增加独立于年龄,性别,心力衰竭(以下简称心衰),肾功能或β阻滞剂、胺碘酮和华法林的联合应用。相关论文8月11日在线发表于《美国心脏病学会杂志》(Journal of the American College of Cardiology,简称JACC)

ACC 2015:地高辛增房颤患者死亡风险达27%

即将在美国心脏病学会年会(ACC 2015)公布的一项研究显示,房颤患者服用地高辛的全因死亡风险较未服用者高27%,心源性死亡风险高21%;而房颤合并肾衰的患者服用地高辛的风险更是比相似病情下、未服用者的死亡风险增加60%~70%。 使用地高辛以前就曾被认为与房颤患者死亡危险增加有关,2012年11月27日发表在《欧洲心脏杂志》上的一篇研究显示,地高辛使用者全因死亡率较未使用者增加41%。 美

BMJ:地高辛的安全性和疗效性(荟萃分析)

为了澄清所有观察性和随机对照试验中地高辛对死亡和临床结果的影响,研究人员对研究设计和方法进行了一项系统性研究和荟萃分析。该研究的数据来源于 Medline, Embase,Cochrane图书馆,参考文献目录的综合文献检索,以及根据一项前瞻性注册设计(PROSPERO:CRD42014010783)正在进行的研究,包括从1960年到2014年7月发表使用地高辛治疗与对照组相比(安慰剂或不治疗)的研

JACC:地高辛的使用和房颤患者的死亡预后无关

    背景  虽然地高辛长期用于治疗心房颤动(AF)和心力衰竭(HF),但其安全性仍有争议。    意义  本研究旨在描述通过HF的存在或不存在被分层的房颤患者在一段时间内使用地高辛被,来表征地高辛的使用和起始的预测因子,以及和地高辛使用相关的预后。    方法  在2010年6月至2011年8月期间,地高

郭艺芳:心衰患者还能使用地高辛治疗吗?

导语:2015年5月4日,欧洲心脏病学杂志(EUROPEAN HEART JOURNAL)发表了VAMOS等人完成的一项荟萃分析[Eur Heart J 2015 May 4]。该研究结果发现,心力衰竭患者应用地高辛治疗可使全因死亡率增高14%。这一结论再次引起人们对于心力衰竭患者应用地高辛治疗的合理性产生质疑。近日,河北省人民医院的郭艺芳老师,对此提出了自己的见解。多年以来,地高辛一直广泛用于治

Circulation AE:地高辛增加房颤患者的死亡率和住院率

地高辛是从植物洋地黄中提取出的药物,已用于控制房颤患者的心率超过100年,在全世界广泛使用。但是支持该用法的数据有限并且有研究发现使用地高辛出现不良后果。因此研究者进行试验研究地高辛和房颤患者(没有心衰症状)死亡率和住院率的关系。研究者Anthony Steimle说:“我们的研究表明在现代临床实践中使用地高辛治疗房颤需要重新评价。”考虑到有其他控制心率的方法,使用地高辛治疗房颤时要特别慎重,特别